It is provided a blood vessel function inspecting apparatus including: a blood vessel diameter measuring portion configured to measure a diameter of a blood vessel; a blood vessel wall thickness measuring portion configured to measure a wall thickness of the blood vessel; and a blood vessel function index value calculating portion configured to calculate a function index value for diagnosing the blood vessel of its function, after releasing of the blood vessel from blood flow obstruction, by dividing an amount of dilatation of said diameter of the blood vessel continuously measured by said blood vessel diameter measuring portion, by the wall thickness measured by said blood vessel wall thickness measuring portion.

An apparatus for analyzing a biosignal is provided. The apparatus includes a communicator configured to receive from an external device a first biosignal of an object detected by the external device; a synchronizer configured to transmit a synchronization signal to from the external device or receive the synchronization signal from the external device; at least one biosignal detector configured to detect a second biosignal of the object according to the synchronization signal; and a processor configured to compare characteristics of the first biosignal and the second biosignal and obtain biometric information having correlation with a result of the comparison.

Provided is an apparatus for analyzing living body information including: a plurality of pulse wave sensors configured to detect a pulse wave signal of an object and disposed on a rear surface of the apparatus; a processor configured to analyze living body information of the object based on the detected pulse wave signal; and a display configured to display the analyzed living body information and disposed on a front surface of the apparatus.

The invention comprises a method of using blood flow parameters to optimize the therapeutic efficacy of an antiplatelet agent in the treatment of a disease or disorder associated with abnormal hemodynamic thrombogenicity in a subject.

The invention relates to a method for establishing and/or monitoring foreign structures in an extracorporeal fluid or in a fluid flow, in particular in blood or a bloodstream, wherein the fluid is monitored by means of ultrasound. The method according to the invention is characterized in that the features of the fluid state established by means of the ultrasound monitoring are processed by means of a multi-criteria ultrasonic analysis. The invention furthermore relates to a device for performing this method and the use of this device.

The approach presented here relates to a determination appliance (100) for determining a viscosity of a fluid. The determination appliance (100) has at least one determination device (110) and a provisioning device (115). The determination device (110) is designed to determine the viscosity of the fluid and/or a rotational speed () of a blade wheel (205) for conveying the fluid by using at least one detected volume flow of the fluid and a detected pressure difference of the fluid. The provisioning device (115) is designed to provide or send a viscosity signal (130) representing the viscosity determined by the determination device (110).

Embodiments provide devices, preparations and methods for delivering therapeutic agents (TAs) such as clotting factors (CFs, e.g., Factor 8) within the GI tract. Many embodiments provide a swallowable device e.g., a capsule for delivering TAs into the intestinal wall (IW). Embodiments also provide TA preparations configured to be contained within the capsule, advanced from the capsule into the IW and/or surrounding tissue (ST) and degrade to release the TA into the bloodstream to produce a therapeutic effect (e.g., improved clotting). The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW or ST (e.g., the peritoneal cavity). Embodiments are particularly useful for delivery of CFs for treatment of clotting disorders (e.g., hemophilia) where such CFs are poorly absorbed and/or degraded within the GI tract.

Provided is a small blood viscosity measurement kit and a cartridge therefor. The small blood viscosity measurement kit configured to measure a blood viscosity includes: a kit body; two blood pipes disposed symmetrically on two sides of the kit body, wherein an upper side of each of the two blood pipes is open and configured to receive blood injected thereinto; and a fine channel connected to a lower side of the each of the two blood pipes. When blood is injected into one of the two blood pipes, the blood is supplied to the other of the two blood pipes through the fine channel. In addition, there is provided a small blood viscosity measurement kit cartridge, in which a plurality of small blood viscosity measurement kits are stored and kept, and the small blood viscosity measurement kit cartridge automatically supplies the small blood viscosity measurement kits.

A capacitive accelerometer device is provided, and includes a capacitive accelerometer module, a display device and a signal line. The capacitive accelerometer module includes one or more capacitive accelerometers for sensing an arterial acceleration pulse wave of a user. The display device includes a displayer and a speaker. The displayer is used to display the arterial acceleration pulse wave of the user. The speaker emits an audible signal according to a change value of the arterial acceleration pulse wave. The display device electrically connects to the capacitive accelerometer module via the signal line. The display device automatically senses the arterial acceleration pulse wave of the user and correspondingly generates the change value. The display device generates a prompt signal when the change value is equal to or larger than a predetermined value.

Devices and methods for vascular navigation, assessment and/or diagnosis are disclosed where a location detection system generally includes an elongate body defining a lumen at least partially along a length of the elongate body. One or more sensors are positioned near or at a distal tip of the elongate body and one or more openings are defined along the elongate body in proximity to the one or more sensors. The one or more openings are configured to control a boundary distance between the one or more sensors and a fluid with a parameter of a known initial value when emitted from the one or more openings. A controller is in communication with the one or more sensors and is configured to track a change in the parameter relating to concentration over the one or more sensors and determine a position of the one or more sensors within a body.